UCSF

ZINC00968256

Substance Information

In ZINC since Heavy atoms Benign functionality
August 6th, 2004 11 Yes

Other Names:

"1-Adamantanamine hydrochloride, 99%"

(a)tadine

mantadine

1-Adamantamine

1-Adamantanamine

1-Adamantanamine (8CI)

1-Adamantanamine HCl

1-Adamantanamine hydrochloride

1-Adamantanamine hydrochloride, 99%

1-Adamantanamine hydrochloride, 99+%

1-Adamantanamine hydrochloride; 1-Adamantanamine, hydrochloride; 1-Adamantylamine hydrochloride; 1-Aminoadamantane hydrochloride; 1-Aminoadamantene hydrochloride; AI3-52211; AMANTADINE HCL; AMANTADINE HYDROCHLORIDE; Adamantanamine hydrochloride; Adamantin

1-AdaMantanaMine Sulfate

1-Adamantanamine, 98%

1-Adamantanamine; 1-Adamantylamine; 1-Aminoadamantane; 1-Aminotricyclo(3.3.1.1(sup 3,7))decane; Adamantanamine; Adamantylamine; Amantadina [INN-Spanish]; Amantadine; Amantadine Sulfate; Amantadine [INN:BAN]; Amantadinum [INN-Latin]; Aminoadamantane; BRN 2

1-adamantanamine; 1-adamantylamine; 1-aminoadamantane; Amantadine; Amantidine; Aminoadamantane; tricyclo[3.3.1.1(3,7)]decan-1-amine; tricyclo[3.3.1.1(3,7)]decan-1-ylamine; tricyclo[3.3.1.1(3,7)]decane-1-amine

1-Adamantylamine

1-Adamantylamine hydrochloride

1-Aminoadamantane

1-Aminoadamantane hydrochloride

1-Aminoadamantane sulfate

1-Aminoadamantane;Adamantamine;Adamantanamine;Adamantylamine;Amantadine Base;Amantadine HCL;Amantadine Hydrochloride;Amantidine;Aminoadamantane

1-Aminotricyclo(3.3.1.1(sup 3,7))decane

138576_ALDRICH

665-66-7 (hydrochloride)

665-66-7; Amantadine hydrochloride (JP16/USP); D00777; Symmetrel (TN)

665-66-7; Amantadine hydrochloride; C07939

665-66-7; CPD001370746; SAM002554881; Symmetrel

768-94-5

768-94-5; Amantadine (INN); D07441

80789-67-9; Adamantamine fumarate; Prestwick_555

AB00514655

AC-11992

AC1L1CZI

AC1Q4UAF

AC1Q5396

ADA

Adamantamine

Adamantamine fumarate

Adamantamine hydrochloride

Adamantan-1-amine

adamantan-1-amine hydrochloride

Adamantan-1-amine sulfate

adamantan-1-aminium

adamantan-1-ylamine

Adamantanamine

Adamantanamine hydrochloride

Adamantane

ADAMANTANE,1-AMINO

Adamantylamine

ADAMANTYLAMINEHYDROCHLORIDE 1-

ADS-5101

ADS-5102

AKOS000113994

AKOS000119324

Amant

Amantadina

Amantadina [INN-Spanish]

amantadina; amantadine; amantadinum

Amantadine

Amantadine (BAN

Amantadine (hydrochloride)

Amantadine (INN)

Amantadine Base

Amantadine HCL

Amantadine hydrochloride (Symmetrel)

AMANTADINE HYDROCHLORIDE; CPD001370746; SAM002554881; Symmetrel

Amantadine sulphate

Amantadine [INN:BAN]

Amantadinum

Amantadinum [INN-Latin]

Amantidine

Ambap768-94-5

Aminoadamantane

BIA4304

BIDD:GT0757

Bio-0821

BPBio1_000368

BRN 2204333

BSPBio_000334

BSPBio_001570

BSPBio_001822

C06818

C10H17N

Cerebramed

CHEBI:2618

CHEMBL660

CID2130

D07441

DAP000781

DB00915

DivK1c_000815

EINECS 212-201-2

Endantadine

EXP-105-1

FDA)

Gen-Amantadine

HMS1791O12

HMS1989O12

Hofcomant

HSDB 3202

I14-1101

IDI1_000815

InChI=1/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H

INN); Amantadine HCl (FDA

INN); Amantadine HCl (JAN

INN); Amantadine Hydrochloride (FDA

JAN

KBio1_000815

KBio2_000390

KBio2_002958

KBio2_005526

KBio3_001322

KBioGR_000548

KBioSS_000390

L000868

LS-157049

Lysovir

Mantadine

Mantadix

MFCD00074723

MFCD00074732

MFCD00077251

MolPort-001-661-700

MolPort-001-760-587

MolPort-001-791-102

NA

NCGC00015036-01

NCGC00015036-07

NCGC00162039-01

NCGC00162039-02

NCGC00162039-03

NCGC00162039-04

NCGC00179597-01

NCIOpen2_001059

NINDS_000815

NSC 341865

NSC-83653

NSC341865

NSC83653

Nurelin

Oprea1_248648

OR14310

Pk-Merz

Prestwick0_000407

Prestwick1_000407

Prestwick2_000407

Prestwick3_000407

QA-8890

SPBio_000002

SPBio_002273

Spectrum2_000081

Spectrum3_000291

Spectrum4_000134

Spectrum5_000772

Spectrum_000030

STK298781

Symadine

Symmetrel

TCMDC-125869

TCMDC-125869; EXP-105-1

TL8005280

Tricyclo(3.3.1.1(3,7))-decan-1-amine

Tricyclo(3.3.1.1(sup 3,7))decan-1-amine

Tricyclo(3.3.1.1(sup 3.7))decan-1-amine

Tricyclo(3.3.1.13,7)decan-1-amine

Tricyclo[3.3.1.1(3,7)]decan-1-amine

tricyclo[3.3.1.1(3,7)]decan-1-ylamine

tricyclo[3.3.1.1(3,7)]decane-1-amine

Tricyclo[3.3.1.1(sup3,7)]decan-1-amine

Tricyclo[3.3.1.1^3,7]decan-1-amine

tricyclo[3.3.1.1~3,7~]decan-1-amine

tricyclo[3.3.1.1~3,7~]decan-1-amine hydrochloride

UNII-BF4C9Z1J53

USAN

USP

USP)

Viregyt; Virosol

Wiregyt

WLN: L66 B6 A B- C 1B ITJ BZ

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.65 3.78 -41.15 3 1 1 28 152.261 0

Vendor Notes

Note Type Comments Provided By
MP 206-208° Oakwood Chemical
MP 298 - 300 Enamine Building Blocks
MP 298...300 Enamine Building Blocks
Melting_Point 360? Alfa-Aesar
Melting_Point 360° Alfa-Aesar
ALOGPS_SOLUBILITY 8.46e-02 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Mp [°C] >300 Acros Organics
biological_use Also has antiparkinsonian props. IBScreen Bioactives
Notes Anti viral activity Apollo Scientific Bioactives
biological_use Antiviral agent IBScreen Bioactives IBScreen Bioactives
therap antiviral, antiparkinsonian; treatment of drug-induced extrapyrimidal reactions MicroSource Spectrum
mechanism Apparent virucidal mechanism: influenza type-A specific IBScreen Bioactives
Melting_Point ca 200? subl. Alfa-Aesar
Melting_Point ca 200° subl. Alfa-Aesar
Target Dopamine Receptor Selleck Chemicals
Therapy Dopamine releaser used in the treatment of Parkinsonism and drug- SMDC MicroSource
mechanism Dopaminergic IBScreen Bioactives IBScreen Bioactives
Patent Database Links EP1256343; EP1321463; EP1420021; EP1561470; EP1568685; EP1576985; EP1579873; EP1600156; EP1625855; EP1649857; EP1661560; EP1685843; EP1714641; EP1772155; EP1785145; EP1801098; EP1815846; EP1829527; EP1829528; EP1829539; EP1832575; EP1834638; EP1837020; EP ChEBI
mechanism Exact virucidal mechanism not completely understood IBScreen Bioactives
H phrase H302: Harmful if swallowed Acros Organics
mechanism influenza type-A viral nucleic-acid into host-cell IBScreen Bioactives
Warnings IRRITANT Matrix Scientific
UniProt Database Links M2_I000F; M2_I000X; M2_I00A0; M2_I00A1; M2_I01A0; M2_I01A1; M2_I01A2; M2_I01A3; M2_I02A0; M2_I02A1; M2_I02A2; M2_I02A3; M2_I02A4; M2_I02A5; M2_I02A6; M2_I02A7; M2_I03A0; M2_I03A1; M2_I05A1; M2_I06A0; M2_I07A0; M2_I18A0; M2_I30A0; M2_I33A0; M2_I34A0; M2_I3 ChEBI
mechanism May cause dopamine release from central sites other than the substantia-nigra IBScreen Bioactives
mechanism May interfere with viral penetration into cells. IBScreen Bioactives
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : A-3954; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 hydrogen chloride NIH Clinical Collection via PubChem
P phrase P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell Acros Organics
mechanism Postulated antiparkinsonian mechanism: causes dopamine release from dopaminergic terminals that may remain in the substantia-nigra of parkinsonian patients IBScreen Bioactives
biological_use prophylactic drug for influenza IBScreen Bioactives
R phrase R22: Harmful if swallowed. Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: A-3954; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem
Purity USP24 APIChem
Patent Database Links WO2006136407 ChEBI
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
SGMR1-6-E Sigma Opioid Receptor (cluster #6 Of 6), Eukaryotic Eukaryotes 20 0.98 Binding ≤ 10μM
Z101821-2-O H2N2 Subtype (cluster #2 Of 3), Other Other 1100 0.76 Functional ≤ 10μM
Z101822-2-O H3N2 Subtype (cluster #2 Of 2), Other Other 630 0.79 Functional ≤ 10μM
Z50652-2-O Influenza A Virus (cluster #2 Of 4), Other Other 9200 0.64 Functional ≤ 10μM
Z80249-2-O MDCK (Kidney Cells) (cluster #2 Of 2), Other Other 1100 0.76 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 20.25 0.98 Binding ≤ 1μM
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 20.25 0.98 Binding ≤ 10μM
Z101821 Z101821 H2N2 Subtype 1100 0.76 Functional ≤ 10μM
Z101822 Z101822 H3N2 Subtype 2700 0.71 Functional ≤ 10μM
Z50652 Z50652 Influenza A Virus 900 0.77 Functional ≤ 10μM
Z80249 Z80249 MDCK (Kidney Cells) 1100 0.76 Functional ≤ 10μM

Analogs ( Draw Identity 99% 90% 80% 70% )